Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q2 2018 · 10-Q
Revenue$354.77K$354.77K+68.5% vs Q2 2017 Net Income$67.71K$67.71KN/M vs Q2 2017 EPS Diluted$0.01$0.01— vs Q2 2017 Gross Profit$207,730+70.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived$18,870N/M Free Cash Flowderived$6,264N/M Margins · derivedGross margin58.6%+0.7 pt vs Q2 2017
Operating margin19.3%+29.6 pt vs Q2 2017
Net margin19.1%+28.2 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 20, 2018 · 51 d after period end